Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Prostate Cancer|Urinary Bladder Cancer
Interventions: OTHER: Injection of 64Cu-DOTA-AE105
Sponsor: Rigshospitalet, Denmark